Axsome Therapeutics (AXSM) Cash from Investing Activities (2015 - 2026)
Axsome Therapeutics recorded quarterly Cash from Investing Activities of -$121000.0 in Q1 2026, down 70.42% quarter-over-quarter from -$71000.0 in Q4 2025, and up 64.2% year-over-year from -$73690.1 in Q1 2025.
Axsome Therapeutics' Cash from Investing Activities history runs 12 years deep, the most recent figure standing at -$121000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 64.2% year-over-year to -$121000.0; the TTM figure through Mar 2026 stood at -$263000.0 (up 48.43% YoY), while the FY2025 annual figure was -$480000.0, down 77.78% from the prior year.
- Cash from Investing Activities came in at -$121000.0 for Q1 2026 at Axsome Therapeutics, down from -$71000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$7000.0 in Q4 2023 to a low of -$53.2 million in Q2 2022.
- A 5-year average of -$3.2 million and a median of -$90000.0 in 2024 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities slumped 281941.64% in 2022 and soared 99.75% in 2023, its largest moves.
- Axsome Therapeutics' Cash from Investing Activities stood at -$181000.0 in 2022, then jumped by 96.13% to -$7000.0 in 2023, then slumped by 328.57% to -$30000.0 in 2024, then slumped by 136.67% to -$71000.0 in 2025, then sank by 70.42% to -$121000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$121000.0, -$71000.0, and -$58000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -121,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -121,000.00 |
| Mar 31, 2026 | -121,000.00 |
| Dec 31, 2025 | -71,000.00 |
| Dec 31, 2025 | -71,000.00 |
| Sep 30, 2025 | -58,000.00 |
| Sep 30, 2025 | -58,000.00 |
| Jun 30, 2025 | -13,000.00 |
| Jun 30, 2025 | -13,000.00 |
| Mar 31, 2025 | -338,000.00 |
| Mar 31, 2025 | -338,000.00 |
| Dec 31, 2024 | -30,000.00 |
| Dec 31, 2024 | -30,000.00 |
| Sep 30, 2024 | -90,000.00 |
| Sep 30, 2024 | -90,000.00 |
| Jun 30, 2024 | -52,000.00 |
| Jun 30, 2024 | -52,000.00 |
| Mar 31, 2024 | -98,000.00 |
| Mar 31, 2024 | -98,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | -371,000.00 |
| Sep 30, 2023 | -371,000.00 |
| Jun 30, 2023 | -133,000.00 |
| Jun 30, 2023 | -133,000.00 |
| Mar 31, 2023 | -71,000.00 |
| Mar 31, 2023 | -71,000.00 |
| Dec 31, 2022 | -181,000.00 |
| Dec 31, 2022 | -181,000.00 |
| Sep 30, 2022 | -66,000.00 |
| Sep 30, 2022 | -66,000.00 |
| Jun 30, 2022 | -53.24 Mn |
| Jun 30, 2022 | -53.24 Mn |
| Mar 31, 2022 | -214,000.00 |
| Mar 31, 2022 | -214,000.00 |
| Dec 31, 2021 | -451.00 |
| Dec 31, 2021 | -451.00 |
| Sep 30, 2021 | -258,677.00 |
| Sep 30, 2021 | -258,677.00 |
| Jun 30, 2021 | -18,877.00 |
| Jun 30, 2021 | -18,877.00 |
| Mar 31, 2021 | -29,995.00 |
| Mar 31, 2021 | -29,995.00 |
| Dec 31, 2020 | -20,287.00 |
| Dec 31, 2020 | -20,287.00 |
| Sep 30, 2020 | -14,845.00 |
| Sep 30, 2020 | -14,845.00 |
| Jun 30, 2020 | -1,428.00 |
| Jun 30, 2020 | -1,428.00 |
| Mar 31, 2020 | -9,331.00 |
| Mar 31, 2020 | -9,331.00 |
| Dec 31, 2019 | -1,461.00 |
| Dec 31, 2019 | -1,461.00 |
| Sep 30, 2019 | -3,196.00 |
| Sep 30, 2019 | -3,196.00 |
| Sep 30, 2018 | -8,481.00 |
| Sep 30, 2018 | -8,481.00 |
| Jun 30, 2018 | -9,639.00 |
| Jun 30, 2018 | -9,639.00 |
| Mar 31, 2018 | -14,576.00 |
| Mar 31, 2018 | -14,576.00 |
| Dec 31, 2017 | -1.00 |
| Dec 31, 2017 | -1.00 |
| Sep 30, 2017 | -3,603.00 |
| Sep 30, 2017 | -3,603.00 |
| Jun 30, 2017 | -3,395.00 |
| Jun 30, 2017 | -3,395.00 |
| Mar 31, 2017 | -2,899.00 |
| Mar 31, 2017 | -2,899.00 |
| Dec 31, 2016 | -6,055.00 |
| Dec 31, 2016 | -6,055.00 |
| Sep 30, 2016 | -76,254.00 |
| Sep 30, 2016 | -76,254.00 |
| Jun 30, 2016 | -11,601.00 |
| Jun 30, 2016 | -11,601.00 |
| Mar 31, 2016 | -10,651.00 |
| Mar 31, 2016 | -10,651.00 |
| Dec 31, 2015 | -4,112.00 |
| Dec 31, 2015 | -4,112.00 |
| Sep 30, 2015 | -4,407.00 |
| Sep 30, 2015 | -4,407.00 |
| Jun 30, 2015 | -1,420.00 |
| Jun 30, 2015 | -1,420.00 |
| Mar 31, 2015 | -10,256.00 |
| Mar 31, 2015 | -10,256.00 |